European Society of Cardiology – 2020 Kazuma Oyama – Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48 Remo Furtado – Efficacy and Safety of dapagliflozin according to baseline blood pressure- Observations from DECLARE-TIMI 58 Trial Anthony Carnicelli – Non-vitamin K antagonist oral anticoagulants vs. warfarin in atrial fibrillation-Individual patient data from the pivotal randomized trials Jan Steffel – Is there a role for half-dose for half-dose anticoagulation in atrial fibrillation – Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48Share this:TwitterFacebookLike this:Like Loading...
